STERIS plc STE NYSE

STERIS plc (STE) reported total assets of $10.15B and total liabilities of $3.53B for fiscal year 2025, resulting in total equity of $6.62B.

The company held $171.7M in cash and short-term investments. Total debt stood at $2.04B, with net debt of $1.87B. The Debt-to-Equity (D/E) ratio was 0.31 (conservative).

Current ratio is 1.96, indicating strong short-term liquidity. Interest coverage is 10x (strong).

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.31, current ratio of 1.96, interest coverage 10x — balance sheet is strong
• MOAT (69/100) — Total assets $10.15B and equity $6.62B support the company's competitive scale
• VALUE (41/100) — Debt-to-Equity 0.31 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 76/100 with 4/7 criteria passed.

SYK

Stryker Corporation

$345.88

-0.39%

BSX

Boston Scientific Corporation

$63.82

+1.01%

PHG

Koninklijke Philips N.V.

$29.09

+1.89%

BIIB

Biogen Inc.

$178.96

+1.47%

DXCM

DexCom, Inc.

$62.95

-0.27%

LH

Labcorp Holdings Inc.

$268.87

+1.78%

DGX

Quest Diagnostics Incorporated

$194.16

+0.65%

WAT

Waters Corporation

$330.98

+1.94%